It has been shown that activation of the S1P pathway and the resultant NF-κB production activates astrocytes to sustain scar formation, and release toxic mediators that contribute to neuroinflammation and neurodegeneration, leading to formation of MS lesions (Colombo et al., 2014). The gene discussed is NFKB1; the disease is myeloid sarcoma.